Geneos Wealth Management’s Nomura Holdings NMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-496
Closed -$3.05K – 3190
2025
Q1
$3.05K Buy
496
+127
+34% +$808 ﹤0.01% 2657
2024
Q4
$2.14K Buy
+369
New +$2.1K ﹤0.01% 2578
2022
Q3
– Sell
-2,267
Closed -$8K – 2389
2022
Q2
$8K Hold
2,267
– – ﹤0.01% 2036
2022
Q1
$9K Hold
2,267
– – ﹤0.01% 2123
2021
Q4
$9K Buy
+2,267
New +$10.3K ﹤0.01% 2222

Other funds holding NMR

Geneos Wealth Management's NMR Position: Q2 2025 in Review

Geneos Wealth Management sold out of Nomura Holdings (NMR) in Q2 2025, closing a stake of 496 shares — an estimated $3.05K sold.

Geneos Wealth Management first reported a position in NMR in Q4 2021 and held it in 5 quarters. The position peaked at $9K in Q1 2022. 207 funds tracked by Wall St. Rank hold NMR as of Q2 2025.

  • Geneos Wealth Management reported no remaining Nomura Holdings position as of Q2 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 496 Nomura Holdings shares in Q2 2025, an estimated $3.05K.
  • Geneos Wealth Management first reported a position in Nomura Holdings in Q4 2021 and held it in 5 quarters.
  • Geneos Wealth Management's Nomura Holdings position peaked at $9K in Q1 2022.
  • 207 funds tracked by Wall St. Rank held Nomura Holdings as of Q2 2025.

Based on Geneos Wealth Management's 13F filing for Q2 2025, filed 18 Aug 2025.